By reducing these hard-to-track costs, your company can focus its budget on getting more products to market.
Today’s companies are making some of the greatest advances in life sciences. In this fast-paced environment of drug discovery, information recommendation and sharing happens outside of official channels. To many R&D employees, the need to obtain data rapidly trumps procedures and policies. For another, it’s challenging — if not impossible — for companies to keep track of journals and articles acquired informally; yet, when the practice is uncontrolled, it can run up major costs.